- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 420.28M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 420.28M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 420.28M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$357.57K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.09M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $223.88K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $390.44K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$6.72M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$6.3M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $7.24M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $6.9M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $7.31M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $7M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $460.39K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $567.87K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $577.58K |
| Total Assets | Q1 2026 · Dec 31, 2025 | $697.5K |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $914.57K |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $973.87K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $333.33K |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $402.7K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.29M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.14M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.25M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.1M |
| Revenue | Q1 2026 · Mar 31, 2025 | $278.63K |